Related Experiment Videos
Outpatient transurethral balloon urethroplasty.
D G Travis1, D R Webb, W S Hare
1Department of Surgery, University of Melbourne, Royal Melbourne Hospital, Victoria, Australia.
The Australian and New Zealand Journal of Surgery
|July 1, 1991
Summary
Transurethral balloon dilatation for benign prostatic hypertrophy showed poor long-term success. This treatment is not recommended due to limited efficacy in patients with bladder outlet obstruction.
Area of Science:
- Urology
- Surgical Innovation
- Medical Device Evaluation
Background:
- Benign prostatic hypertrophy (BPH) commonly causes bladder outlet obstruction.
- Transurethral balloon dilatation (TBD) is a minimally invasive BPH treatment option.
- Efficacy of TBD for BPH requires further clinical investigation.
Purpose of the Study:
- To evaluate the symptomatic and urodynamic outcomes of transurethral balloon dilatation.
- To assess the long-term effectiveness of TBD in patients with BPH.
Main Methods:
- Six patients with BPH underwent transurethral balloon dilatation.
- Pre- and post-procedure assessments included symptomatic and urodynamic criteria.
- Average follow-up duration was 11.7 months.
Main Results:
- Only one patient achieved a successful outcome.
- Five patients experienced initial improvement, but results were not sustained.
- Long-term efficacy was significantly limited.
Conclusions:
- Transurethral balloon dilatation is not recommended for BPH treatment.
- Limited success rates suggest it should only be considered in exceptional cases.
- Further research into alternative BPH treatments is warranted.